GETECCU:炎症性腸疾患における卓越性を目指す包括的な国家戦略
Yamile Zabana1,2, Ana Gutiérrez2,3,4, Manuel Barreiro-de Acosta5,6
1Hospital Universitari MútuaTerrassa, Plaça Dr. Robert, 5, Terrassa 08221, Barcelona, Spain.
Therapeutic advances in gastroenterology
|February 16, 2026
まとめ
スペインのクローン病と潰瘍性大腸炎に関する作業部会 (GETECCU) は,国内登録 (ENEIDA) と品質認証プログラムを通じて,炎症性腸疾患 (IBD) の治療と研究を大幅に進めてきました.
科学分野:
- 胃腸内科 胃腸内科
- クリニック・リサーチ 臨床研究
- 医療サービス 研究 医療サービス
背景:
- クローン病と潰瘍性大腸炎に関するスペインのワーキンググループ (GETECCU) は1990年に設立されました.
- GETECCUは,スペインのIBD研究,品質保証,教育のための主要なプラットフォームに発展しました.
- 炎症性腸疾患の分野における国内および国際的な協力を促進してきました.
研究 の 目的:
- GETECCUの構造,業績,戦略的将来の方向性について概要を述べる.
- IBDの臨床ケアと科学的知識の進歩におけるGETECCUの役割を強調する.
- IBDにおける全国学術グループ開発のモデルとしてGETECCUを紹介する.
主な方法:
- ENEIDA (Estudio Nacional en Enfermedad Inflamatoria Intestinal sobre Determinantes Genéticos y Ambientales) の全国的な将来的なレジストリの開発と維持. 遺伝的および環境的決定因子に関する炎症性腸内疾患に関する国立研究室).
- IBDユニットのための卓越ユニット認定プログラムの実施.
- GETECCUヤンググループと国際協力を通じて,キャリアの初期におけるリーダーシップの育成.
主要な成果:
- ENEIDAのレジストリには,100以上のセンターと8万5千人の患者のデータが含まれ,多くの観察研究と翻訳研究をサポートしています.
- IBDのユニット80社以上が現在,卓越ユニット認定プログラムで認定されています.
- GETECCUは,国際的プレゼンスを拡大し,世界的なIBDイニシアチブに積極的に参加しています.
結論:
- GETECCUは,スペインのIBD研究の礎となり,IBDケアにおける革新と品質の推進力となっています.
- この組織は,科学的知識を臨床実践に効果的に翻訳し,専門医療への平等なアクセスを促進しています.
- GETECCUは,IBDの管理を改善するための全国学術グループの成功した進化を例示しています.
関連する概念動画
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
915
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
915
01:29Inflammatory Bowel Disease IV: Pharmacological Management
795
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
795
01:21Inflammatory Bowel Disease V: Surgical Management
702
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
702
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
544
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
544